Phoenix Pharmaceuticals, Inc. provides over 7000 peptide-related products and organic molecules to researchers worldwide. The company synthesizes simple as well as exotic peptides, including phosphorylation, biotinylation, reduced bonds, multiple disulfide bridges, peptidomimetics, and organic or sugar groups attached. Specializing in obesity, cardiovascular disease and diabetes, the company offers purity up to 99% and quantities from mg to Kg for both pre-clinical and clinical studies.